ClinEdge White Papers

 

whitepaper_Site Milestones

Reaching Revenue Milestones and Overcoming Pain Points

As the clinical research industry continues to evolve, research sites are constantly looking for ways to obtain a competitive edge over other sites in the industry while also continuing to grow financially and reach their revenue goals. It is inevitable that sites climbing the revenue ladder will encounter various pain points.

VIEW WHITE PAPER ON SITE MILESTONES

 

whitepaper-travel

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

Placing an emphasis on patient retention is necessary for the success of a clinical trial. For many patients, participating in a trial is a major undertaking. Depending on the protocol requirements, study visits can be draining. There are a number of reasons why a patient may commit to participating in a trial only to drop out down the road.

VIEW WHITE PAPER ON PATIENT TRAVEL

 

rare-disease-whitepaper.png

The Rare Disease Patient's Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. In this white paper, we will discuss the typical healthcare experience of a rare disease patient in the United States, ways to develop a trial around patients’ unique needs, and how to collaborate with rare disease patients to recruit for your study.

VIEW WHITE PAPER ON RARE DISEASE

 

Branding Your Clinical Trial

There are thousands of clinical trials currently enrolling patients at any given time; how can you make yours stand out from the rest? What will help patients relate to, and sites remember, a clinical trial? The answer lies within your trial’s visual branding.

VIEW WHITE PAPER ON BRANDING

 

whitepaper-joinnetwork.jpg
 Why Your Site Could Benefit from Joining a Site Network

Sponsors and CROs are constantly seeking streamlined approaches to access high quality research sites suitable for their trials. One of the most efficient ways that a site can push themselves further up the site selection list is by joining a reputable site network. Learn about more benefits to joining a site network in our white paper.

VIEW WHITE PAPER ON JOINING A SITE NETWORK
 
 What to Include in Your Website Redesign

As the internet evolves and adapts to new devices, functions, and technology, you may find your once “cutting edge” clinical website is beginning to look dated or not function properly across the different devices potential patients are using to access your website. Learn more about what to include in your website redesign to ensure your finished product is exactly as expected!

VIEW WHITE PAPER ON WEBSITE REDESIGN
 
whitepaper.jpg

A Simple Guide to Social Media for Clinical Trials

The terms “social media” and “social networks” refer to an expanding web of internet-based platforms which permit users to instantaneously share content with friends, neighbors, and the world at large. These networks also provide a remote medium for people to make connections, build relationships and organize into online communities. If current trends hold, the importance of social media in clinical research is only going to increase.

VIEW WHITE PAPER ON SOCIAL MEDIA
 
whitepaper-1.jpg

Facebook As a Patient Recruitment Tool

Many organizations, including big name pharma companies and research sites all over the world, are taking advantage of the full power of social media to recruit patients to clinical trials. According to Brandwatch.com, of the 7 billion people in the world, over 3 billion are internet users, and over 2 billion are social media users.

VIEW WHITE PAPER ON FACEBOOK

 

What Sponsors & CROs Really Want to See in a Site’s Feasibility Questionnaire

When it is time for sponsors and CROs to determine which sites are right for their studies, a feasibility questionnaire is a site’s first opportunity to make an impression and to decide on whether the study may be a good match. In this white paper, Christian Burns, President of ClinEdge, discusses strategies that sites often overlook when submitting their feasibilities.

VIEW WHITE PAPER ON FEASIBILITY QUESTIONNAIRES